Unaudited Condensed Consolidated Statements of Operations - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2026	Sep. 30, 2025	Sep. 30, 2026	Sep. 30, 2025
Revenues
Product revenue, net	$ 107,648	$ 115,361	$ 308,955	$ 330,095
Collaboration revenue	560	734	5,175	2,464
Total revenues	108,208	116,095	314,130	332,559
Expenses
Cost of product revenue	(51,305)	(46,764)	(137,782)	(128,219)
Cost of collaboration revenue	0	(119)	(20)	(531)
Research and development	(49,810)	(47,928)	(177,167)	(159,271)
Selling, general, and administrative	(70,071)	(70,106)	(208,013)	(204,566)
Loss from operations	(62,978)	(48,822)	(208,852)	(160,028)
Interest income	5,731	8,345	18,057	25,794
Interest expenses	(1,577)	(1,400)	(4,801)	(3,848)
Foreign currency gains	10,528	6,422	40,430	9,909
Other income (expense), net	288	(508)	5,735	3,045
Loss before income tax	(48,008)	(35,963)	(149,431)	(125,128)
Income tax benefit	1,872	0	1,454	0
Net loss	$ (46,136)	$ (35,963)	$ (147,977)	$ (125,128)
Loss per share - basic (in dollars per share)	$ (0.04)	$ (0.03)	$ (0.13)	$ (0.11)
Loss per share - diluted (in dollars per share)	$ (0.04)	$ (0.03)	$ (0.13)	$ (0.11)
Weighted-average shares used in calculating net loss per ordinary share - basic (in shares)	1,123,397,940	1,102,072,680	1,116,916,210	1,091,690,340
Weighted-average shares used in calculating net loss per ordinary share - diluted (in shares)	1,123,397,940	1,102,072,680	1,116,916,210	1,091,690,340